精选 · 医疗保健

Lab tools & diagnostics

由 InspectStocks 整理Published 2026年10月14日20 companies0 followers

Instruments, supplies and testing services for labs, drugmakers and doctors.

借助 AI 模型分组，并经我们的编辑审核。每家公司下方的一行说明它为何在这里。

Download image

卡片梯队

股价为 2026年11月11日收盘价，来自 IEX 交易所数据。

Grade mix

A 8B 8C 2D 1F 1

Revenue growing

19 of 20

Free cash flow growing

9 of 20

Median price move, 1 year

+22.0%

Sort by

TMOTHERMO FISHER SCIENTIFIC INC.
Diagnostics and researchMarket cap US$265.9BP/E 37.85
US$717.62+22.5%1Y
Since added +8.2%
A+
成长与现金
强劲增长
Business trend
加速
Business quality
强
Getting better
在改善
Revenue
US$47.4B+8.3%
Profit
US$7.1B+7.6%
Free cash flow
US$7.6B+24.3%
Discuss
Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
DHRDANAHER CORPORATION
Diagnostics and researchMarket cap US$165.5BP/E 38.51
US$235.31+8.0%1Y
Since added +5.4%
B+
成长与现金
强劲增长
Business trend
加速
Business quality
强
Getting better
在改善
Revenue
US$25.6B+5.5%
Profit
US$4.3B+23.6%
Free cash flow
US$5.7B+14.2%
Discuss
Why it is here: Sells research instruments, supplies and services
AAGILENT TECHNOLOGIES, INC.
Diagnostics and researchMarket cap US$49.9BP/E 34.89
US$176.91+17.6%1Y
Since added +3.1%
B+
成长与现金
强劲增长
Business trend
加速
Business quality
强
Getting better
在改善
Revenue
US$7.4B+8.6%
Profit
US$1.4B+18.0%
Free cash flow
US$1.3B+16.5%
Discuss
Why it is here: Sells lab instruments, consumables and software to labs and drug makers
WATWaters Corporation
Diagnostics and researchMarket cap US$46.3BP/E 202.08
US$470.84+21.5%1Y
Since added +9.7%
D
成长与现金
在增长
Business trend
放缓
Business quality
参差
Getting better
参差
Revenue
US$5.6B+84.2%
Profit
US$98.6M-84.8%
Free cash flow
US$290.8M-51.7%
Discuss
Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
MTDMettler-Toledo International Inc.
Diagnostics and researchMarket cap US$34.8BP/E 37.95
US$1,749.30+20.8%1Y
Since added +9.4%
B+
成长与现金
强劲增长
Business trend
平稳
Business quality
强
Getting better
在改善
Revenue
US$4.2B+6.5%
Profit
US$934.1M+11.8%
Free cash flow
US$870.6M-2.1%
Discuss
Why it is here: Makes precision laboratory instruments and weighing equipment
ILMNIllumina, Inc.
Diagnostics and researchMarket cap US$32.2BP/E 36.64
US$212.86+74.5%1Y
Since added -21.5%
A+
成长与现金
强劲增长
Business trend
平稳
Business quality
强
Getting better
明显改善
Revenue
US$4.5B+5.8%
Profit
US$895M+27.5%
Free cash flow
US$1.1B+5.7%
Discuss
Why it is here: Sells DNA sequencing instruments and reagents
IDXXIDEXX LABORATORIES INC /DE
Diagnostics and researchMarket cap US$55.4BP/E 47.37
US$703.00-1.5%1Y
Since added +35.2%
A+
成长与现金
强劲增长
Business trend
平稳
Business quality
强
Getting better
明显改善
Revenue
US$4.7B+11.9%
Profit
US$1.2B+15.1%
Free cash flow
US$1.3B+35.3%
Discuss
Why it is here: Sells veterinary diagnostic tests and instruments
DGXQuest Diagnostics Inc
Diagnostics and researchMarket cap US$28.5BP/E 25.77
US$258.72+40.8%1Y
Since added +12.2%
A
成长与现金
强劲增长
Business trend
平稳
Business quality
稳健
Getting better
在改善
Revenue
US$11.8B+9.1%
Profit
US$1.1B+16.5%
Free cash flow
US$1.4B-1.3%
Discuss
Why it is here: Provides diagnostic testing and clinical lab services
LHLABCORP HOLDINGS INC.
Diagnostics and researchMarket cap US$30.2BP/E 30.53
US$372.18+41.3%1Y
Since added +18.7%
A
成长与现金
强劲增长
Business trend
平稳
Business quality
参差
Getting better
明显改善
Revenue
US$14.6B+6.0%
Profit
US$1B+17.4%
Free cash flow
US$1.3B-6.8%
Discuss
Why it is here: Provides diagnostic tests and clinical lab services
RVTYREVVITY, INC
Diagnostics and researchMarket cap US$17.7BP/E 70.32
US$158.22+68.5%1Y
Since added +2.0%
A
成长与现金
强劲增长
Business trend
平稳
Business quality
参差
Getting better
在改善
Revenue
US$2.9B+4.6%
Profit
US$253.2M+6.6%
Free cash flow
US$590.5M+18.7%
Discuss
Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
IQVIQVIA HOLDINGS INC.
Diagnostics and researchMarket cap US$45.2BP/E 33.38
US$274.37+24.2%1Y
Since added +5.2%
A
成长与现金
强劲增长
Business trend
平稳
Business quality
参差
Getting better
在改善
Revenue
US$17.3B+8.8%
Profit
US$1.4B+8.7%
Free cash flow
US$2.1B-6.0%
Discuss
Why it is here: Runs clinical trials and sells healthcare data to drugmakers
NTRANATERA, INC.
Diagnostics and researchMarket cap US$46.4B无市盈率（经营亏损）
US$319.77+52.6%1Y
Since added -19.2%
B-
成长与现金
强劲增长
Business trend
平稳
Business quality
弱
Getting better
参差
Revenue
US$2.9B+37.4%
Profit
-US$164.7M+46.7%
Free cash flow
US$52.5M-50.5%
Discuss
Why it is here: Provides genetic and cell-free DNA diagnostic tests
TECHBIO-TECHNE Corp
BiotechnologyMarket cap US$11.4BP/E 66.77
US$72.78+19.2%1Y
Since added +0.4%
A+
成长与现金
强劲增长
Business trend
加速
Business quality
强
Getting better
明显改善
Revenue
US$1.2B+0.9%
Profit
US$172M+120.5%
Free cash flow
US$308.2M+37.6%
Discuss
Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
BRKRBRUKER CORPORATION
Medical devicesMarket cap US$9.5B无市盈率（经营亏损）
US$62.41+47.5%1Y
Since added +11.0%
B
成长与现金
强劲增长
Business trend
放缓
Business quality
参差
Getting better
参差
Revenue
US$3.5B+2.2%
Profit
-US$123.4M-490.4%
Free cash flow
US$244.7M+2,408.5%
Discuss
Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
RGENREPLIGEN CORP
Medical instruments and suppliesMarket cap US$9.8BNo P/E
US$172.68+9.3%1Y
Since added -1.6%
B
成长与现金
强劲增长
Business trend
放缓
Business quality
参差
Getting better
在改善
Revenue
US$805.6M+13.8%
Profit
-US$11.8M-779.2%
Free cash flow
US$106.7M-3.0%
Discuss
Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
BIOBIO-RAD LABORATORIES, INC.
Medical devicesMarket cap US$10.4B无市盈率（经营亏损）
US$386.08+18.0%1Y
Since added +6.1%
C
成长与现金
在增长
Business trend
平稳
Business quality
稳健
Getting better
在改善
Revenue
US$2.6B+1.4%
Profit
US$1B+251.3%
Free cash flow
US$329.1M-2.3%
Discuss
Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
QGENQIAGEN N.V.
Diagnostics and researchMarket cap US$10.9BP/E 25.93
US$50.30+19.8%1Y
Since added +10.7%
B+
成长与现金
强劲增长
Business trend
平稳
Business quality
强
Getting better
在改善
Revenue
US$2.1B+2.1%
Profit
US$384.5M-5.2%
Free cash flow
US$436.2M-8.9%
Discuss
Why it is here: Supplies sample preparation and molecular testing kits and instruments
GHGUARDANT HEALTH, INC.
Diagnostics and researchMarket cap US$20.9B无市盈率（经营亏损）
US$154.76+58.2%1Y
Since added -4.5%
B
成长与现金
强劲增长
Business trend
平稳
Business quality
参差
Getting better
参差
Revenue
US$1.3B+41.7%
Profit
-US$485.1M-21.6%
Free cash flow
-US$232.1M+11.5%
Discuss
Why it is here: Provides blood-based cancer diagnostic tests
MEDPMedpace Holdings, Inc.
Diagnostics and researchMarket cap US$18.6BP/E 36.90
US$664.52+11.2%1Y
Since added +9.0%
C+
成长与现金
强劲增长
Business trend
放缓
Business quality
强
Getting better
明显改善
Revenue
US$2.8B+20.4%
Profit
US$517.8M+19.6%
Free cash flow
US$667.6M-1.4%
Discuss
Why it is here: Runs clinical trials for biotech and pharma drug developers
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Diagnostics and researchMarket cap US$16.4BP/E 353.20
US$342.61+99.8%1Y
Since added +14.5%
F
成长与现金
参差
Business trend
收缩
Business quality
参差
Getting better
参差
Revenue
US$4B-1.2%
Profit
US$40.2M+148.8%
Free cash flow
US$399.6M-26.5%
Discuss
Why it is here: Provides preclinical research models and testing services to drug developers

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Be civil and stick to the companies. Comments are opinions, not advice.

Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.